Immuron Limited

Ticker IMRN

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in Melbourne, Australia

Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a microbiome company focused on developing and commercialising oral immunotherapeutics for the treatment of many gut mediated diseases. Immuron has a unique and safe technology platform that enables a shorter development therapeutic cycle.

Visit website

REPORT RATINGS

4.8 / 5.0 (94)

Immuron Limited reports have an aggregate usefulness score of 4.8 based on 94 reviews.

Immuron Limited